|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
UroToday, CA - 2 hours ago There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
UroToday, CA - 4 hours ago There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
UroToday, CA - 6 hours ago There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
UroToday, CA - 8 hours ago There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
UroToday, CA - 10 hours ago There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Sciele Pharma and Plethora Solutions Announce Final Analysis of …
MarketWatch - Dec 8, 2008 There are currently no approved pharmaceutical treatments for premature ejaculation. In May 2007, Plethora signed an exclusive license agreement with Sciele … |
|
Sciele Pharma and Plethora Solutions Announce Positive Phase III …
PR-Inside.com (Pressemitteilung), Austria - Nov 9, 2008 European Phase III double-blind placebo-controlled study of PSD502 for the treatment of premature ejaculation ('PE') has met its three co-primary endpoints … |
|
Plethora premature ejaculation drug meets goals
Reuters UK, UK - Nov 6, 2008 L: Quote, Profile, Research) said on Friday its premature ejaculation drug has met all of its goals in a phase III trial. The company said PSD502, … Sciele Pharma and Plethora Solutions Announce Positive Phase III … Business Wire (press release) Plethora: Plethora reports positive outcomes of European Phase III … Proactive Investors UK Plethora hits target in European trial ShareCast Hemscott - GrowthBusiness.co.uk all 14 news articles |